Invention Grant
US07595051B2 Methods of treating neovascular glaucoma, macular degeneration and capillary proliferation with alphavbeta3-specific antibodies
失效
治疗新生血管性青光眼，黄斑变性和毛细血管增生的方法与alphavbeta3特异性抗体
- Patent Title: Methods of treating neovascular glaucoma, macular degeneration and capillary proliferation with alphavbeta3-specific antibodies
- Patent Title (中): 治疗新生血管性青光眼，黄斑变性和毛细血管增生的方法与alphavbeta3特异性抗体
-
Application No.: US11980211Application Date: 2007-10-30
-
Publication No.: US07595051B2Publication Date: 2009-09-29
- Inventor: Peter C. Brooks , David A. Cheresh
- Applicant: Peter C. Brooks , David A. Cheresh
- Applicant Address: US CA La Jolla
- Assignee: The Scripps Research Institute
- Current Assignee: The Scripps Research Institute
- Current Assignee Address: US CA La Jolla
- Agent Hugh Wang; Thomas Fitting
- Main IPC: A61K39/395
- IPC: A61K39/395 ; C07K16/28
Abstract:
The present invention describes methods for inhibition angiogenesis in tissues using vitronectin αvβ3 antagonists, and particularly for inhibiting angiogenesis in inflamed tissues and in tumor tissues and metastases using therapeutic compositions containing αvβ3 antagonists.
Public/Granted literature
- US20080175840A1 Methods for treating angiogenesis related disorders Public/Granted day:2008-07-24
Information query
